open/close global search bar

21 July 2018 by Bruce Bloom

Conference talk

RareRepurposing - Opportunities and Challenges

About the author

profile picture of Bruce Bloom

Bruce Bloom

CEO

Cures Within Reach

United States

Comments (0)

Related Content

Neladenoson bialanate in patients with chronic HFpEF (PANACHE) thumbnail image

Conference talk

22 July 2018

{{GlobalController.truncateTitle("Neladenoson bialanate in patients with chronic HFpEF (PANACHE)", 65)}}
ACE2 Therapy in PAH thumbnail image

Conference talk

22 July 2018

{{GlobalController.truncateTitle("ACE2 Therapy in PAH", 65)}}
PET-CT Imaging with [89Zr]-bevacizumab thumbnail image

Conference talk

22 July 2018

{{GlobalController.truncateTitle("PET-CT Imaging with [89Zr]-bevacizumab", 65)}}
Dichloroacetate for PAH thumbnail image

Conference talk

22 July 2018

{{GlobalController.truncateTitle("Dichloroacetate for PAH", 65)}}
PB1046, a longacting, VPAC-2 specific VIP analogue for PAH thumbnail image

Conference talk

21 July 2018

{{GlobalController.truncateTitle("PB1046, a longacting, VPAC-2 specific VIP analogue for PAH", 65)}}

Add to reading list

Please enter a list name.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg